$ATRX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Adhera Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Adhera Therapeutics, Inc.. Get notifications about new insider transactions in Adhera Therapeutics, Inc. for free.
Page: < prev 1 2 3 4 5 6 ... 9 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.43 | 4,400 | 6,292 | 2,810,570 | 2.8 M to 2.8 M (-0.16 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.42 | 2,800 | 3,976 | 2,814,970 | 2.8 M to 2.8 M (-0.10 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.41 | 1,500 | 2,115 | 2,817,770 | 2.8 M to 2.8 M (-0.05 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.40 | 5,200 | 7,280 | 2,819,270 | 2.8 M to 2.8 M (-0.18 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.39 | 4,500 | 6,255 | 2,824,470 | 2.8 M to 2.8 M (-0.16 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.38 | 6,292 | 8,683 | 2,828,970 | 2.8 M to 2.8 M (-0.22 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.37 | 208 | 285 | 2,835,262 | 2.8 M to 2.8 M (-0.01 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.35 | 2,700 | 3,645 | 2,835,470 | 2.8 M to 2.8 M (-0.10 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.33 | 2,057 | 2,736 | 2,838,170 | 2.8 M to 2.8 M (-0.07 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.32 | 1,943 | 2,565 | 2,840,227 | 2.8 M to 2.8 M (-0.07 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.31 | 2,500 | 3,275 | 2,842,170 | 2.8 M to 2.8 M (-0.09 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.30 | 2,000 | 2,600 | 2,844,670 | 2.8 M to 2.8 M (-0.07 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.29 | 200 | 258 | 2,846,670 | 2.8 M to 2.8 M (-0.01 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.27 | 1,000 | 1,270 | 2,846,870 | 2.8 M to 2.8 M (-0.04 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.26 | 2,700 | 3,402 | 2,847,870 | 2.9 M to 2.8 M (-0.09 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.25 | 2,100 | 2,625 | 2,850,570 | 2.9 M to 2.9 M (-0.07 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.24 | 1,800 | 2,232 | 2,852,670 | 2.9 M to 2.9 M (-0.06 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.23 | 800 | 984 | 2,854,470 | 2.9 M to 2.9 M (-0.03 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.22 | 1,000 | 1,220 | 2,855,270 | 2.9 M to 2.9 M (-0.04 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.59 | 100 | 159 | 2,856,270 | 2.9 M to 2.9 M (0.00 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.58 | 700 | 1,106 | 2,856,370 | 2.9 M to 2.9 M (-0.02 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.56 | 8,600 | 13,416 | 2,857,070 | 2.9 M to 2.9 M (-0.30 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.55 | 400 | 620 | 2,865,670 | 2.9 M to 2.9 M (-0.01 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.54 | 8,400 | 12,936 | 2,866,070 | 2.9 M to 2.9 M (-0.29 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.53 | 3,300 | 5,049 | 2,874,470 | 2.9 M to 2.9 M (-0.11 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.53 | 500 | 763 | 2,877,770 | 2.9 M to 2.9 M (-0.02 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.52 | 600 | 914 | 2,878,270 | 2.9 M to 2.9 M (-0.02 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.52 | 6,400 | 9,728 | 2,878,870 | 2.9 M to 2.9 M (-0.22 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.51 | 2,900 | 4,379 | 2,885,270 | 2.9 M to 2.9 M (-0.10 %) |
Jan 21 2011 | MRNA | Marina Biotech, In ... | Novartis Bioventures Ltd | 10% Owner | Sell | S | 1.50 | 10,900 | 16,350 | 2,888,170 | 2.9 M to 2.9 M (-0.38 %) |
Oct 15 2010 | MRNA | Marina Biotech, In ... | GARCIA PETER S | Chief Financial Off ... | Option Exercise | A | 2.45 | 22,500 | 55,125 | 22,500 | |
Oct 15 2010 | MRNA | Marina Biotech, In ... | FRENCH J MICHAEL | President and CEO | Option Exercise | A | 2.45 | 79,700 | 195,265 | 79,700 | |
Jul 23 2010 | MRNA | Marina Biotech, In ... | LI CHIANG J | Director | Option Exercise | A | 2.98 | 11,500 | 34,298 | 11,500 | |
Jul 23 2010 | MRNA | Marina Biotech, In ... | Parker Peter | Director | Option Exercise | A | 2.98 | 11,500 | 34,298 | 11,500 | |
Jul 23 2010 | MRNA | Marina Biotech, In ... | Taylor Michael Douglas | Director | Option Exercise | A | 2.98 | 11,500 | 34,298 | 11,500 | |
Jul 23 2010 | MRNA | Marina Biotech, In ... | Karis James | Director | Option Exercise | A | 2.98 | 11,500 | 34,298 | 11,500 | |
Jul 23 2010 | MRNA | Marina Biotech, In ... | SESSLER GREGORY | Director | Option Exercise | A | 2.98 | 12,938 | 38,586 | 12,938 | |
Aug 11 2009 | MRNA | Marina Biotech, In ... | Karis James | Director | Option Exercise | A | 1.53 | 34,500 | 52,785 | 34,500 | |
Jul 15 2009 | MRNA | Marina Biotech, In ... | GARCIA PETER S | Chief Financial Off ... | Option Exercise | A | 3.39 | 120,000 | 406,800 | 120,000 | |
Jul 15 2009 | MRNA | Marina Biotech, In ... | GARCIA PETER S | Chief Financial Off ... | Option Exercise | A | 2.39 | 120,000 | 286,800 | 120,000 | |
Jul 15 2009 | MRNA | Marina Biotech, In ... | GARCIA PETER S | Chief Financial Off ... | Option Exercise | A | 1.39 | 120,000 | 166,800 | 120,000 | |
May 21 2009 | MRNA | Marina Biotech, In ... | THAW BRUCE R/FA | Director | Option Exercise | A | 1.52 | 74,750 | 113,620 | 74,750 | |
May 21 2009 | MRNA | Marina Biotech, In ... | SESSLER GREGORY | Director | Option Exercise | A | 1.52 | 51,750 | 78,660 | 51,750 | |
May 21 2009 | MRNA | Marina Biotech, In ... | Rothman James | Director | Option Exercise | A | 1.52 | 46,000 | 69,920 | 46,000 | |
May 21 2009 | MRNA | Marina Biotech, In ... | PETERS DANIEL | Director | Option Exercise | A | 1.52 | 46,000 | 69,920 | 46,000 | |
May 21 2009 | MRNA | Marina Biotech, In ... | YORK BRUCE R | CFO and Secretary | Option Exercise | A | 1.52 | 120,000 | 182,400 | 120,000 | |
May 21 2009 | MRNA | Marina Biotech, In ... | POLISKY BARRY | Chief Scientific Of ... | Option Exercise | A | 1.52 | 120,000 | 182,400 | 120,000 | |
May 21 2009 | MRNA | Marina Biotech, In ... | FRENCH J MICHAEL | President and CEO | Option Exercise | A | 1.52 | 240,000 | 364,800 | 240,000 | |
Mar 20 2009 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | Director | Option Exercise | J | 12.94 | 800,000 | 10,352,000 | 1,704,247 | |
Mar 20 2009 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | Director | Option Exercise | J | 25.00 | 100,000 | 2,500,000 | 2,504,247 | |
Mar 20 2009 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | Director | Option Exercise | J | 14.72 | 600,000 | 8,832,000 | 2,604,247 | |
Mar 20 2009 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | Director | Grant | A | 0.00 | 731,275 | 0 | 1,166,504 | 435.2 K to 1.2 M (+168.02 %) |
Jan 05 2009 | MRNA | Marina Biotech, In ... | POLISKY BARRY | Chief Scientific Of ... | Option Exercise | A | 2.35 | 120,000 | 282,000 | 360,000 | |
Jan 05 2009 | MRNA | Marina Biotech, In ... | POLISKY BARRY | Chief Scientific Of ... | Option Exercise | A | 1.35 | 120,000 | 162,000 | 240,000 | |
Jan 05 2009 | MRNA | Marina Biotech, In ... | POLISKY BARRY | Chief Scientific Of ... | Option Exercise | A | 0.35 | 120,000 | 42,000 | 120,000 | |
Aug 05 2008 | MRNA | Marina Biotech, In ... | Costantino Henry R | CSO - Delivery | Payment of Exercise | F | 1.11 | 438 | 486 | 24,047 | 24.5 K to 24 K (-1.79 %) |
Aug 11 2008 | MRNA | Marina Biotech, In ... | FRENCH J MICHAEL | CEO | Buy | P | 0.75 | 200 | 150 | 10,000 | 9.8 K to 10 K (+2.04 %) |
Aug 11 2008 | MRNA | Marina Biotech, In ... | FRENCH J MICHAEL | CEO | Buy | P | 0.80 | 944 | 754 | 9,800 | 8.9 K to 9.8 K (+10.66 %) |
Aug 11 2008 | MRNA | Marina Biotech, In ... | FRENCH J MICHAEL | CEO | Buy | P | 0.76 | 100 | 76 | 8,856 | 8.8 K to 8.9 K (+1.14 %) |
Aug 11 2008 | MRNA | Marina Biotech, In ... | FRENCH J MICHAEL | CEO | Buy | P | 0.75 | 1,756 | 1,317 | 8,756 | 7 K to 8.8 K (+25.09 %) |
Aug 11 2008 | MRNA | Marina Biotech, In ... | FRENCH J MICHAEL | CEO | Buy | P | 0.75 | 7,000 | 5,250 | 7,000 | 0 to 7 K |
Jul 16 2008 | MRNA | Marina Biotech, In ... | Costantino Henry R | CSO - Delivery | Sell | S | 1.01 | 231 | 233 | 24,485 | 24.7 K to 24.5 K (-0.93 %) |
Jul 03 2008 | MRNA | Marina Biotech, In ... | Costantino Henry R | CSO - Delivery | Sell | S | 1.17 | 240 | 281 | 24,716 | 25 K to 24.7 K (-0.96 %) |
Jul 03 2008 | MRNA | Marina Biotech, In ... | Costantino Henry R | CSO - Delivery | Sell | S | 1.19 | 81 | 96 | 24,956 | 25 K to 25 K (-0.32 %) |
Jul 02 2008 | MRNA | Marina Biotech, In ... | Duffy Timothy M | Chief Business Offi ... | Sell | S | 1.19 | 200 | 238 | 56,395 | 56.6 K to 56.4 K (-0.35 %) |
May 14 2008 | MRNA | Marina Biotech, In ... | CROSS ALEXANDER D | Director | Grant | A | 1.26 | 10,000 | 12,635 | 38,000 | 28 K to 38 K (+35.71 %) |
May 13 2008 | MRNA | Marina Biotech, In ... | THAW BRUCE R/FA | Director | Buy | P | 1.13 | 4,086 | 4,617 | 164,041 | 160 K to 164 K (+2.55 %) |
May 13 2008 | MRNA | Marina Biotech, In ... | THAW BRUCE R/FA | Director | Buy | P | 1.14 | 800 | 912 | 159,955 | 159.2 K to 160 K (+0.50 %) |
May 13 2008 | MRNA | Marina Biotech, In ... | THAW BRUCE R/FA | Director | Buy | P | 1.15 | 36,602 | 42,092 | 159,155 | 122.6 K to 159.2 K (+29.87 %) |
May 13 2008 | MRNA | Marina Biotech, In ... | THAW BRUCE R/FA | Director | Buy | P | 1.23 | 2,500 | 3,075 | 122,553 | 120.1 K to 122.6 K (+2.08 %) |
May 13 2008 | MRNA | Marina Biotech, In ... | THAW BRUCE R/FA | Director | Buy | P | 1.24 | 1,900 | 2,356 | 120,053 | 118.2 K to 120.1 K (+1.61 %) |
May 13 2008 | MRNA | Marina Biotech, In ... | THAW BRUCE R/FA | Director | Buy | P | 1.33 | 4,112 | 5,469 | 118,153 | 114 K to 118.2 K (+3.61 %) |
May 12 2008 | MRNA | Marina Biotech, In ... | Stanewick Gerald T | Director | Buy | P | 1.14 | 10,000 | 11,400 | 116,412 | 106.4 K to 116.4 K (+9.40 %) |
Apr 02 2008 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | Chairman and CEO | Buy | J | 2.00 | 3,500 | 6,991 | 434,459 | 431 K to 434.5 K (+0.81 %) |
Apr 02 2008 | MRNA | Marina Biotech, In ... | BRANDT GORDON | President | Buy | J | 2.00 | 1,201 | 2,399 | 41,705 | 40.5 K to 41.7 K (+2.97 %) |
Jun 12 2008 | MRNA | Marina Biotech, In ... | PETERS DANIEL | Director | Option Exercise | A | 1.19 | 45,000 | 53,550 | 45,000 | |
Jun 12 2008 | MRNA | Marina Biotech, In ... | YORK BRUCE R | CFO and Secretary | Option Exercise | A | 3.19 | 120,000 | 382,800 | 389,000 | |
Jun 12 2008 | MRNA | Marina Biotech, In ... | YORK BRUCE R | CFO and Secretary | Option Exercise | A | 2.19 | 120,000 | 262,800 | 269,000 | |
Jun 12 2008 | MRNA | Marina Biotech, In ... | YORK BRUCE R | CFO and Secretary | Option Exercise | A | 1.19 | 120,000 | 142,800 | 149,000 | |
Jun 12 2008 | MRNA | Marina Biotech, In ... | THAW BRUCE R/FA | Director | Option Exercise | A | 1.19 | 70,000 | 83,300 | 176,000 | |
Jun 12 2008 | MRNA | Marina Biotech, In ... | SESSLER GREGORY | Director | Option Exercise | A | 1.19 | 60,000 | 71,400 | 60,000 | |
Jun 12 2008 | MRNA | Marina Biotech, In ... | Rothman James | Director | Option Exercise | A | 3.19 | 104,370 | 332,940 | 358,111 | |
Jun 12 2008 | MRNA | Marina Biotech, In ... | Rothman James | Director | Option Exercise | A | 2.19 | 104,370 | 228,570 | 253,741 | |
Jun 12 2008 | MRNA | Marina Biotech, In ... | Rothman James | Director | Option Exercise | A | 1.19 | 104,371 | 124,201 | 149,371 | |
Jun 12 2008 | MRNA | Marina Biotech, In ... | Rothman James | Director | Option Exercise | A | 1.19 | 45,000 | 53,550 | 45,000 | |
Jun 12 2008 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | Chairman and CSO | Option Exercise | A | 5.19 | 220,000 | 1,141,800 | 3,204,247 | |
Jun 12 2008 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | Chairman and CSO | Option Exercise | A | 4.19 | 220,000 | 921,800 | 2,984,247 | |
Jun 12 2008 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | Chairman and CSO | Option Exercise | A | 3.19 | 420,000 | 1,339,800 | 2,764,247 | |
Jun 12 2008 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | Chairman and CSO | Option Exercise | A | 2.19 | 420,000 | 919,800 | 2,344,247 | |
Jun 12 2008 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | Chairman and CSO | Option Exercise | A | 1.19 | 420,000 | 499,800 | 1,924,247 | |
Jun 12 2008 | MRNA | Marina Biotech, In ... | POLLOCK JOHN V | Director | Option Exercise | A | 1.19 | 55,000 | 65,450 | 137,500 | |
Jun 12 2008 | MRNA | Marina Biotech, In ... | CROSS ALEXANDER D | Director | Option Exercise | A | 1.19 | 45,000 | 53,550 | 83,000 | |
Jun 12 2008 | MRNA | Marina Biotech, In ... | BAYH SUSAN B | Director | Option Exercise | A | 1.19 | 55,000 | 65,450 | 87,500 | |
Mar 19 2008 | MRNA | Marina Biotech, In ... | Stanewick Gerald T | Director | Buy | P | 2.40 | 4,100 | 9,840 | 106,412 | 102.3 K to 106.4 K (+4.01 %) |
Mar 19 2008 | MRNA | Marina Biotech, In ... | Stanewick Gerald T | Director | Buy | P | 2.39 | 900 | 2,151 | 102,312 | 101.4 K to 102.3 K (+0.89 %) |
Feb 19 2008 | MRNA | Marina Biotech, In ... | Duffy Timothy M | Chief Business Offi ... | Option Exercise | A | 2.22 | 35,000 | 77,700 | 87,984 | |
Feb 19 2008 | MRNA | Marina Biotech, In ... | Duffy Timothy M | Chief Business Offi ... | Grant | A | 0.00 | 14,400 | 0 | 56,595 | 71 K to 56.6 K (-20.28 %) |
Feb 19 2008 | MRNA | Marina Biotech, In ... | YORK BRUCE R | Interim CFO, Secret ... | Option Exercise | A | 2.22 | 29,000 | 64,380 | 29,000 | |
Feb 19 2008 | MRNA | Marina Biotech, In ... | YORK BRUCE R | Interim CFO, Secret ... | Grant | A | 0.00 | 14,400 | 0 | 35,232 | 49.6 K to 35.2 K (-29.01 %) |
Dec 20 2007 | MRNA | Marina Biotech, In ... | BRANDT GORDON | President | Option Exercise | A | 3.86 | 36,000 | 138,960 | 129,699 | |
Dec 20 2007 | MRNA | Marina Biotech, In ... | BRANDT GORDON | President | Grant | A | 0.00 | 18,000 | 0 | 40,504 | 22.5 K to 40.5 K (+79.99 %) |
Dec 20 2007 | MRNA | Marina Biotech, In ... | BRANDT GORDON | President | Payment of Exercise | F | 3.60 | 661 | 2,380 | 22,504 | 23.2 K to 22.5 K (-2.85 %) |
Dec 07 2007 | MRNA | Marina Biotech, In ... | YORK BRUCE R | Chief Actg Officer, ... | Buy | P | 4.04 | 2,000 | 8,080 | 20,832 | 18.8 K to 20.8 K (+10.62 %) |
Nov 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 14.85 | 1,000 | 14,850 | 305,287 | 306.3 K to 305.3 K (-0.33 %) |
Nov 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 14.73 | 167 | 2,460 | 306,287 | 306.5 K to 306.3 K (-0.05 %) |
Nov 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 14.71 | 200 | 2,942 | 306,454 | 306.7 K to 306.5 K (-0.07 %) |
Nov 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 14.70 | 133 | 1,955 | 306,654 | 306.8 K to 306.7 K (-0.04 %) |
Nov 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 14.42 | 400 | 5,768 | 306,787 | 307.2 K to 306.8 K (-0.13 %) |
Nov 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 14.41 | 100 | 1,441 | 307,187 | 307.3 K to 307.2 K (-0.03 %) |
Nov 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 14.20 | 1,000 | 14,200 | 307,287 | 308.3 K to 307.3 K (-0.32 %) |
Oct 11 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 16.05 | 500 | 8,025 | 308,287 | 308.8 K to 308.3 K (-0.16 %) |
Oct 11 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 16.00 | 1,000 | 16,000 | 308,787 | 309.8 K to 308.8 K (-0.32 %) |
Oct 09 2007 | MRNA | Marina Biotech, In ... | Costantino Henry R | Chief Scientific Of ... | Option Exercise | A | 14.85 | 29,000 | 430,650 | 35,666 | |
Oct 09 2007 | MRNA | Marina Biotech, In ... | Costantino Henry R | Chief Scientific Of ... | Grant | A | 0.00 | 14,400 | 0 | 25,037 | 10.6 K to 25 K (+135.38 %) |
Oct 09 2007 | MRNA | Marina Biotech, In ... | JOHNSON PAUL H | Sr VP of R&D, CSO | Payment of Exercise | F | 15.23 | 660 | 10,052 | 29,301 | 30 K to 29.3 K (-2.20 %) |
Oct 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 14.00 | 100 | 1,400 | 309,787 | 309.9 K to 309.8 K (-0.03 %) |
Oct 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.91 | 100 | 1,391 | 309,887 | 310 K to 309.9 K (-0.03 %) |
Oct 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.80 | 200 | 2,760 | 309,987 | 310.2 K to 310 K (-0.06 %) |
Oct 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.75 | 400 | 5,500 | 310,187 | 310.6 K to 310.2 K (-0.13 %) |
Oct 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.73 | 200 | 2,746 | 310,587 | 310.8 K to 310.6 K (-0.06 %) |
Oct 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.70 | 100 | 1,370 | 310,787 | 310.9 K to 310.8 K (-0.03 %) |
Oct 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.65 | 200 | 2,730 | 310,887 | 311.1 K to 310.9 K (-0.06 %) |
Oct 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.63 | 200 | 2,726 | 311,087 | 311.3 K to 311.1 K (-0.06 %) |
Oct 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.62 | 200 | 2,724 | 311,287 | 311.5 K to 311.3 K (-0.06 %) |
Oct 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.61 | 100 | 1,361 | 311,487 | 311.6 K to 311.5 K (-0.03 %) |
Oct 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.60 | 200 | 2,720 | 311,587 | 311.8 K to 311.6 K (-0.06 %) |
Oct 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.48 | 300 | 4,044 | 311,787 | 312.1 K to 311.8 K (-0.10 %) |
Oct 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.38 | 200 | 2,676 | 312,087 | 312.3 K to 312.1 K (-0.06 %) |
Oct 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.30 | 200 | 2,660 | 312,287 | 312.5 K to 312.3 K (-0.06 %) |
Oct 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.25 | 100 | 1,325 | 312,487 | 312.6 K to 312.5 K (-0.03 %) |
Oct 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 13.20 | 100 | 1,320 | 312,587 | 312.7 K to 312.6 K (-0.03 %) |
Oct 02 2007 | MRNA | Marina Biotech, In ... | WENIG DEVIN | Director | Sell | S | 12.90 | 100 | 1,290 | 312,687 | 312.8 K to 312.7 K (-0.03 %) |
Sep 28 2007 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | Chairman, President ... | Sell | S | 13.42 | 200 | 2,684 | 430,959 | 431.2 K to 431 K (-0.05 %) |
Sep 28 2007 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | Chairman, President ... | Sell | S | 13.53 | 1,000 | 13,530 | 431,159 | 432.2 K to 431.2 K (-0.23 %) |
Sep 28 2007 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | Chairman, President ... | Sell | S | 13.52 | 2,000 | 27,040 | 432,159 | 434.2 K to 432.2 K (-0.46 %) |
Sep 28 2007 | MRNA | Marina Biotech, In ... | QUAY STEVEN C | Chairman, President ... | Sell | S | 13.81 | 2,000 | 27,623 | 434,159 | 436.2 K to 434.2 K (-0.46 %) |
Sep 12 2007 | MRNA | Marina Biotech, In ... | Stanewick Gerald T | Director | Sell | S | 14.21 | 4,200 | 59,695 | 101,412 | 105.6 K to 101.4 K (-3.98 %) |
Sep 10 2007 | MRNA | Marina Biotech, In ... | Ranker Philip C | Chief Financial Off ... | Payment of Exercise | F | 14.05 | 69 | 969 | 46,312 | 46.4 K to 46.3 K (-0.15 %) |
Sep 10 2007 | MRNA | Marina Biotech, In ... | YORK BRUCE R | Chief Actg Officer, ... | Payment of Exercise | F | 14.05 | 53 | 745 | 18,832 | 18.9 K to 18.8 K (-0.28 %) |
Sep 07 2007 | MRNA | Marina Biotech, In ... | JOHNSON PAUL H | Sr VP of R&D, CSO | Option Exercise | X | 10.39 | 2,667 | 27,710 | 8,833 | |
Sep 07 2007 | MRNA | Marina Biotech, In ... | JOHNSON PAUL H | Sr VP of R&D, CSO | Option Exercise | X | 9.36 | 54,649 | 511,515 | 11,500 | |
Sep 07 2007 | MRNA | Marina Biotech, In ... | JOHNSON PAUL H | Sr VP of R&D, CSO | Sell | S | 14.30 | 2,200 | 31,460 | 29,961 | 32.2 K to 30 K (-6.84 %) |
Sep 07 2007 | MRNA | Marina Biotech, In ... | JOHNSON PAUL H | Sr VP of R&D, CSO | Buy | M | 10.39 | 2,667 | 27,710 | 32,161 | 29.5 K to 32.2 K (+9.04 %) |
Sep 07 2007 | MRNA | Marina Biotech, In ... | JOHNSON PAUL H | Sr VP of R&D, CSO | Sell | S | 14.30 | 45,000 | 643,509 | 29,494 | 74.5 K to 29.5 K (-60.41 %) |
Sep 07 2007 | MRNA | Marina Biotech, In ... | JOHNSON PAUL H | Sr VP of R&D, CSO | Buy | M | 9.36 | 54,649 | 511,515 | 74,494 | 19.8 K to 74.5 K (+275.38 %) |
Aug 23 2007 | MRNA | Marina Biotech, In ... | JOHNSON PAUL H | Sr VP of R&D, CSO | Option Exercise | X | 9.36 | 1,339 | 12,533 | 66,149 | |
Aug 23 2007 | MRNA | Marina Biotech, In ... | JOHNSON PAUL H | Sr VP of R&D, CSO | Option Exercise | X | 9.36 | 28,058 | 262,623 | 67,488 | |
Aug 23 2007 | MRNA | Marina Biotech, In ... | JOHNSON PAUL H | Sr VP of R&D, CSO | Option Exercise | X | 9.36 | 5,954 | 55,729 | 95,546 | |
Aug 23 2007 | MRNA | Marina Biotech, In ... | JOHNSON PAUL H | Sr VP of R&D, CSO | Sell | S | 14.30 | 1,100 | 15,734 | 19,845 | 20.9 K to 19.8 K (-5.25 %) |
Aug 23 2007 | MRNA | Marina Biotech, In ... | JOHNSON PAUL H | Sr VP of R&D, CSO | Buy | M | 9.36 | 1,339 | 12,533 | 20,945 | 19.6 K to 20.9 K (+6.83 %) |